⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
September 14, 2026 Deadline Approaching: Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN) – Contact Levi & Korsinsky
accessnewswire.com
REGN
Pomerantz LLP Informs Shareholders of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Urged to Join Class Action Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
Pomerantz LLP Notifies Investors of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Flow Cytometry Market worth $10.57 billion by 2034 - Exclusive Report by MarketsandMarkets™
prnewswire.com
DHR
BDX
WTRG
HOLX
BIIB
GILD
AMGN
BMY
MRK
PFE
ABBV
REGN
VRTX
ISRG
ROST
TMO
SONY
BIO
CYTK
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
globenewswire.com
REGN
Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action - Contact Levi & Korsinsky
accessnewswire.com
REGN